PF-AtlasClinical Trials › NCT07612865

People's Hospital of Xinjiang Uygur Autonomous Region

ERAS group · Not specified

Registry ID
NCT07612865
Phase
Not specified
Status
Completed
Drug / intervention
ERAS group
Sponsor
People's Hospital of Xinjiang Uygur Autonomous Region
Start
2022-09-05
Enrollment
160
Locations
1

About this trial

Objective: To evaluate the impact of enhanced recovery after surgery (ERAS)-based nursing intervention on venous thromboembolism (VTE) and lymphedema after radical hysterectomy for cervical cancer. Methods: In this prospective randomized controlled trial, 160 patients scheduled for radical hysterectomy during September 2022-September 2024 were randomized to an ERAS group (n = 80) or a control group (n = 80). The control group received conventional perioperative care, while the ERAS group received a multimodal perioperative care protocol. Primary outcomes were the 6-month incidence of VTE and lower limb lymphedema. Secondary outcomes included recovery indicators, inflammatory and coagulation markers, quality of life \[QoL; assessed by the Quality of Life Questionnaire-Core 30 (QLQ-C30)\], and nursing satisfaction.

View NCT07612865 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT07612865 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.